Suppr超能文献

骨髓液稀释流式细胞术分析中骨髓涂片的常规化处理。

Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.

机构信息

HematoLogics, Inc. Seattle, Washington 98121, USA.

出版信息

Cytometry B Clin Cytom. 2009 Jan;76(1):27-36. doi: 10.1002/cyto.b.20429. Epub 2008 Jun 11.

Abstract

The use of flow cytometric enumeration of blasts in bone marrow aspirates has been of limited value in situations where blood contamination of the specimen is present. Assessment of sequential pulls of bone marrow aspirates from the same patient show decreasing proportions of blasts that are detected in later specimens. To address this problem, the intensity of CD16 on maturing neutrophils was compared for bone marrow biopsies, peripheral blood, and bone marrow aspirates. A comparison between bone marrow biopsy and aspirate specimens from the same individuals showed similar proportions of neutrophils with mature phenotype in most, but not all pairs. Other cell populations (total mature lymphocytes, monocytes, neutrophils, and blasts) were also similar between the two specimen types, with one exception of a patient with myelodysplasia, exhibiting a unique blast population in the biopsy that was not evident in the aspirate. The proportion of mature myeloid cells expressing a mature neutrophil phenotype (high levels of CD16) was found to be 17% (±6.7, n=47) in trephine marrow biopsy specimens. In contrast, marrow aspirates contained more of the mature neutrophil phenotype (38%±16, n=33) with about 1/3 of the aspirates indistinguishable from biopsies. Using a simple formula to normalize the aspirate specimens to the average neutrophil composition of marrow biopsies, it was possible to correct for the dilutional effect of added blood to both normal bone marrow aspirates and aspirates with elevated blast counts. These results suggest three alternative means of circumventing the problem of blood dilution of marrow aspirate specimens. (1) Blast counts by flow cytometry can be obtained from disaggregated biopsy specimens. (2) A bone marrow aspirate can be assessed for the proportion of mature neutrophils present and only those with low proportions (<30%) of phenotypic mature neutrophils are considered adequate for blast counting. (3) The aspirates with high proportions of mature neutrophils may be normalized based on the proportion of dim CD16 maturing myeloid cells to a level observed in bone marrow biopsies (based on an average mature neutrophil composition). Such an approach for identifying the amount of hemodilution in each specimen may enhance the utility of flow cytometry in enumeration of blasts in bone marrow, especially in cases where myeloblast count is crucial for prognosis, such as myelodysplastic syndromes (MDS).

摘要

流式细胞术检测骨髓抽吸物中的原始细胞在血液污染标本的情况下应用价值有限。评估来自同一患者的连续抽吸骨髓的样本显示,后续样本中检测到的原始细胞比例逐渐降低。为了解决这个问题,比较了骨髓活检、外周血和骨髓抽吸物中成熟中性粒细胞 CD16 的强度。对同一患者的骨髓活检和抽吸标本进行比较,大多数但不是所有标本中都显示具有成熟表型的中性粒细胞比例相似。其他细胞群体(总成熟淋巴细胞、单核细胞、中性粒细胞和原始细胞)在两种标本类型之间也相似,只有一例骨髓增生异常患者的标本例外,该患者的活检中存在独特的原始细胞群体,而抽吸物中则不明显。发现表达成熟中性粒细胞表型(高水平 CD16)的成熟髓细胞比例在骨髓活检标本中为 17%(±6.7,n=47)。相比之下,骨髓抽吸物中含有更多的成熟中性粒细胞表型(38%±16,n=33),大约 1/3 的抽吸物与活检标本无法区分。使用一个简单的公式将抽吸物标本归一化为骨髓活检标本中平均中性粒细胞组成,可以纠正添加血液对正常骨髓抽吸物和原始细胞计数升高的抽吸物的稀释效应。这些结果表明了三种避免骨髓抽吸物标本血液稀释问题的替代方法。(1)可以从离散的活检标本中获得流式细胞术的原始细胞计数。(2)可以评估骨髓抽吸物中存在的成熟中性粒细胞比例,只有那些具有低比例(<30%)的表型成熟中性粒细胞的标本才被认为适合用于原始细胞计数。(3)可以根据成熟髓细胞的弱 CD16 表达比例(基于平均成熟中性粒细胞组成),将高比例成熟中性粒细胞的抽吸物归一化为骨髓活检标本中观察到的水平。这种方法可以识别每个标本中血液稀释的程度,从而提高流式细胞术在骨髓中计数原始细胞的效用,特别是在原始细胞计数对预后至关重要的情况下,如骨髓增生异常综合征(MDS)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验